Terumo Europe and University Medical Center Utrecht (UMC Utrecht) announced that they signed a Memorandum of Understanding (MoU) to recognize the longstanding partnership in the field of oncology.
Terumo Corporation (TSE: 4543) today announced it has completed the acquisition of Quirem Medical B.V., a Netherlands-based healthcare startup specializing in the development of next-generation microspheres for Selective Internal Radiation Therapy (SIRT),